Harbour Investments, Inc. Black Diamond Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$5.18 - $8.48 $279 - $457	-54 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $42 - $62	-5 Reduced 8.47%	54 $0
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $12 - $28	-1 Reduced 1.67%	59 $1,000
Q1 2021 Aug 17, 2021	BUY	$22.23 - $34.75 $1,311 - $2,050	59 Added 5900.0%	60 $1,000
Q1 2021 May 12, 2021	BUY	$22.23 - $34.75 $22 - $34	1 New	1 $0

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $89.8M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.